{{ phone }} {{ location }}

Emergo by UL logo

         

China Medical Device Regulatory Strategy Report

China's medical device market, currently in a rapid state of expansion, is regulated by the National Medical Products Administration (NMPA), formerly the China Food and Drug Administration or CFDA. All medical devices must receive NMPA approval before they can be marketed in the country, though Class I devices are subject to a simpler notification process.

Chinese medical device regulations requires local testing for all but the lowest-risk devices, regardless of whether tests have been performed elsewhere, for NMPA approval.

Eligibility for market clearance in China also requires a manufacturer to have prior approval in the device’s country of origin (or country of manufacture).

Let Emergo assist you in navigating medical device registration in China and the NMPA approval framework as it applies to your device(s).

Emergo relies on our global network of in-house consultants, as well as industry and regulatory contacts, to provide our Regulatory Pathway service. Our country report for the Chinese medical device market offers incisive, actionable analysis including:

  • NMPA Regulatory Background
  • Product Assessment Based on NMPA Criteria
  • Device Classification
  • In-Country Representation Requirements for China
  • Medical Device Registration Requirements
  • Labeling and Language Requirements
  • Costs and Timeframes
  • Post-Market Vigilance Requirements

Please contact us for more information about our Regulatory Strategy Report for China.